-1.78%
Today
Loading 1D prices…
Company profile
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Ra'anana, United States
Employees
2
Fiscal year end
1231
CIK
1893645
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| FEMYFemasys Inc. Common Stock | $23.3M | $2.3M | -812.27% | -$0.47 | +1.46% | Buy |
| ARAYAccuray Incorporated Common Stock | $29.9M | $401.9M | -12.24% | -$0.40 | +4.17% | Hold |
| BEATHeartbeam Inc. Common Stock | $22.9M | $0.00 | — | -$0.62 | -0.98% | Buy |
| MODDModular Medical Inc. Common Stock | $20.7M | $0.00 | — | -$12.36 | -3.79% | Unrated |
| RVPRetractable Technologies Inc. Common Stock | $20.4M | $38.3M | -32.84% | -$0.43 | -2.86% | Unrated |